Literature DB >> 26314774

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

R Dummer1, A Hauschild2, N Lindenblatt3, G Pentheroudakis4, U Keilholz5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26314774     DOI： 10.1093/annonc/mdv297

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  91 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

Review 2.  Nanoparticles as a promising method to enhance the abscopal effect in the era of new targeted therapies.

Authors:  Ignacio Morales-Orue; Rodolfo Chicas-Sett; Pedro C Lara
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-22

Review 3.  A review of guidelines for lung cancer.

Authors:  Paolo Bironzo; Massimo Di Maio
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

4.  Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional Survey.

Authors:  Pinkie Chambers; Kenneth K C Man; Vivian W Y Lui; Sheila Mpima; Paola Nasuti; Martin D Forster; Ian C K Wong
Journal:  JCO Oncol Pract       Date:  2020-03-11

5.  Risk Factors of Subsequent Primary Melanomas in Austria.

Authors:  Christoph Müller; Judith Wendt; Sabine Rauscher; Raute Sunder-Plassmann; Erika Richtig; Ingrid Fae; Gottfried Fischer; Ichiro Okamoto
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

6.  Identification of melanoma cells: a method based in mean variance of signatures via spectral densities.

Authors:  Esperanza Guerra-Rosas; Josué Álvarez-Borrego; Aracely Angulo-Molina
Journal:  Biomed Opt Express       Date:  2017-03-15       Impact factor: 3.732

7.  Quality of Cancer Surveillance Clinical Practice Guidelines: Specificity and Consistency of Recommendations.

Authors:  Ryan P Merkow; Deborah Korenstein; Rubaya Yeahia; Peter B Bach; Shrujal S Baxi
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

Review 8.  Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.

Authors:  Sohita Dhillon
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

9.  Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review.

Authors:  Daniela Pierscianek; Yahya Ahmadipour; Marvin Darkwah Oppong; Laurèl Rauschenbach; Sied Kebir; Martin Glas; Ulrich Sure; Ramazan Jabbarli
Journal:  Mol Neurobiol       Date:  2019-02-04       Impact factor: 5.590

10.  Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.

Authors:  Paolo A Ascierto; Sanjiv S Agarwala; Gennaro Ciliberto; Sandra Demaria; Reinhard Dummer; Connie P M Duong; Soldano Ferrone; Silvia C Formenti; Claus Garbe; Ruth Halaban; Samir Khleif; Jason J Luke; Lluis M Mir; Willem W Overwijk; Michael Postow; Igor Puzanov; Paul Sondel; Janis M Taube; Per Thor Straten; David F Stroncek; Jennifer A Wargo; Hassane Zarour; Magdalena Thurin
Journal:  J Transl Med       Date:  2017-11-16       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.